Intelligent Bio Solutions Share Holder Equity 2020-2025 | INBS

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Intelligent Bio Solutions share holder equity from 2020 to 2025. Share holder equity can be defined as the sum of preferred and common equity items

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Intelligent Bio Solutions share holder equity from 2020 to 2025. Share holder equity can be defined as the sum of preferred and common equity items

Related Stocks
Company Name	Market Cap
Danaher (DHR)	$146.8B
CVS Health (CVS)	$91.2B
Elevance Health (ELV)	$69.8B
Cencora (COR)	$56.3B
DiDi Global (DIDIY)	$26.4B
Labcorp Holdings (LH)	$23.2B
Natera (NTRA)	$22.4B
BioMerieux (BMXMF)	$17.4B
EUROFINS SCIENT (ERFSF)	$14.9B
ICON (ICLR)	$14.1B
Medpace Holdings (MEDP)	$13.3B
CochLear (CHEOY)	$13B
Solventum (SOLV)	$12.6B
Viatris (VTRS)	$12.1B
Caris Life Sciences,�Inc (CAI)	$10.7B
Revvity (RVTY)	$10.3B
Avantor (AVTR)	$9B
Charles River Laboratories (CRL)	$8B
Sonic Healthcare (SKHHY)	$7.8B
HealthEquity (HQY)	$7.6B
Bausch + Lomb (BLCO)	$5.2B
Sotera Health (SHC)	$4.7B
BrightSpring Health Services (BTSG)	$4.2B
Amplifon S.p.A (AMFPF)	$3.9B
GeneDx Holdings (WGS)	$3.7B
Alignment Healthcare (ALHC)	$3.2B
Concentras Parent (CON)	$3B
Surgery Partners (SGRY)	$2.9B
Organon (OGN)	$2.4B
KindlyMD (NAKA)	$2.4B